EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Prognostic Significance of Cdc42 Expression in Colorectal Cancer and Its Concordance Between Primary Tumors and Matched Metastases: A Retrospective Observational Study

Oktay Halit Aktepe iD, Osman Butun, Olcay Kurtulan, Aziz Karaoglu, Suayib Yalcin

Journal of Clinical Medicine · 16.05.2026 · 15 (10) · 3848

DOI: 10.3390/jcm15103848 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 16.05.2026. Verfasst von Oktay Halit Aktepe und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Dokuz Eylül University, Izmir 35330, Turkey. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The Department of Scientific Research Projects Coordination Unit of Hacettepe University, Department of Scientific Research Projects Coordination Unit of Hacettepe University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Objectives: Aberrant activation or overexpression of cell division cycle 42 (Cdc42) has been demonstrated in various tumors; however, its prognostic relevance in colorectal cancer (CRC) remains insufficiently defined. Thus, we evaluated the prognostic impact of Cdc42 expression in patients with CRC. In a paired primary–metastasis subset, we also assessed the concordance of Cdc42 expression between primary tumors and matched metastatic tissues. Materials and Methods: Cdc42 expression was assessed by immunohistochemistry in patients with colorectal cancer who underwent colectomy for curative or palliative purposes between January 2009 and January 2019. Cdc42 expression was quantified as a staining index and then dichotomized into low- and high-Cdc42 groups using a median cutoff value of six. Overall survival (OS) was analyzed by Kaplan–Meier curves with log-rank testing, and independent prognostic factors were assessed using Cox proportional hazard models.

Results

The study included 94 patients (median age, 60 years) with a median follow-up of 88.4 months. High Cdc42 expression was significantly associated with Kirsten rat sarcoma viral oncogene homolog (KRAS) wild-type status (p = 0.001), lymph node metastasis (p = 0.039), and perineural invasion (p = 0.021). Patients with high Cdc42 expression had significantly poorer OS than those with low expression (median OS: 48.5 months, 95% confidence interval [CI]: 33.3–63.7 vs. 114.4 months, 95% CI: 24.0–204.9; p = 0.003). In multivariable Cox regression, high Cdc42 expression remained an independent predictor of worse OS (hazard ratio [HR]: 2.365, 95% CI: 1.336–4.184; p = 0.003), together with advanced stage and moderate-to-poor differentiation. In the paired primary–metastasis subset, Cdc42 expression in primary tumors correlated positively with that in matched metastases (Spearman ρ = 0.416, p = 0.016), whereas no overall directional shift between paired primary and metastatic samples was observed (Wilcoxon signed-rank test: Z = 0.423, p = 0.672).

Conclusions

High Cdc42 expression may serve as an adverse prognostic marker in CRC. Cdc42 shows moderate concordance between primary tumors and matched metastases without a consistent directional shift.

Schlagwörter

Stichwörter der Autor:innen

Cdc42colorectal canceroverall survivalprognostic biomarker

Autor:innen und Institutionen

  • Department of Medical Oncology, Dokuz Eylül University, Izmir 35330, Turkey.
  • Department of Medical Oncology, Acibadem Izmir Kent Hospital, Izmir 35620, Turkey.
  • Department of Pathology, Faculty of Medicine, Hacettepe University, Ankara 06230, Turkey.
  • Department of Medical Oncology, Hacettepe University Cancer Institute, Ankara 06230, Turkey.

ORCID-Profile: Oktay Halit Aktepe

Förderung

  • The Department of Scientific Research Projects Coordination Unit of Hacettepe University
  • Department of Scientific Research Projects Coordination Unit of Hacettepe University

Zitieren

APA

Aktepe, O. H., Butun, O., Kurtulan, O., Karaoglu, A., & Yalcin, S. (2026). Prognostic Significance of Cdc42 Expression in Colorectal Cancer and Its Concordance Between Primary Tumors and Matched Metastases: A Retrospective Observational Study. Journal of Clinical Medicine, 15(10), 3848. https://doi.org/10.3390/jcm15103848

Vancouver

Aktepe OH, Butun O, Kurtulan O, Karaoglu A, Yalcin S. Prognostic Significance of Cdc42 Expression in Colorectal Cancer and Its Concordance Between Primary Tumors and Matched Metastases: A Retrospective Observational Study. Journal of Clinical Medicine. 2026;15(10):3848. doi:10.3390/jcm15103848

BibTeX
@article{Aktepe2026,
  author = {Aktepe, Oktay Halit and Butun, Osman and Kurtulan, Olcay and Karaoglu, Aziz and Yalcin, Suayib},
  title = {Prognostic Significance of Cdc42 Expression in Colorectal Cancer and Its Concordance Between Primary Tumors and Matched Metastases: A Retrospective Observational Study},
  journal = {Journal of Clinical Medicine},
  year = {2026},
  volume = {15},
  number = {10},
  pages = {3848},
  doi = {10.3390/jcm15103848}
}
Kostenlos starten →